Sanofi Files 6-K Report
Ticker: SNYNF · Form: 6-K · Filed: Jul 18, 2025 · CIK: 1121404
| Field | Detail |
|---|---|
| Company | Sanofi (SNYNF) |
| Form Type | 6-K |
| Filed Date | Jul 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, disclosure, pharmaceutical
TL;DR
Sanofi filed a 6-K on 7/18/25, standard disclosure from Paris HQ.
AI Summary
On July 18, 2025, Sanofi filed a Form 6-K with the SEC, reporting information as of the same date. The filing indicates Sanofi's principal executive offices are located at 46 Avenue de la Grande Armée, 75017 Paris, France. The company is registered under the standard industrial classification for Pharmaceutical Preparations.
Why It Matters
This filing provides routine updates and disclosures for Sanofi, a major pharmaceutical company, to the SEC and its investors.
Risk Assessment
Risk Level: low — This is a routine SEC filing (Form 6-K) that typically contains standard corporate information and disclosures, not material events.
Key Players & Entities
- Sanofi (company) — Registrant
- July 18, 2025 (date) — Filing Date
- 46 Avenue de la Grande Armée, 75017 Paris, France (location) — Principal Executive Offices
- 001-31368 (other) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on July 18, 2025.
Where are Sanofi's principal executive offices located?
Sanofi's principal executive offices are located at 46 Avenue de la Grande Armée, 75017 Paris, France.
What is Sanofi's SEC File Number?
Sanofi's SEC File Number is 001-31368.
What is Sanofi's Standard Industrial Classification code?
Sanofi's Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 18, 2025 regarding Sanofi (SNYNF).